Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    Sun Pharma gets Australia TGA nod for ILUMYA to treat plaque psoriasisSun Pharma gets Australia TGA nod for ILUMYA to treat plaque psoriasis
    Aspen Pharma suffers week of woe as valuation tumbles by $3 billionAspen Pharma suffers week of woe as valuation tumbles by $3 billion
    Takeda gets European panel nod for Alunbrig to treat lung cancerTakeda gets European panel nod for Alunbrig to treat lung cancer
    Soon Indian Standard for medical devices, says VK PaulSoon Indian Standard for medical devices, says VK Paul
    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max HealthcareOwners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare
    Australian Competition and Consumer Commission clears Arrow ,Apotex merger: StridesAustralian Competition and Consumer Commission clears Arrow ,Apotex merger: Strides
    ICRA upgrades long-term credit rating of Fortis HealthcareICRA upgrades long-term credit rating of Fortis Healthcare
    AstraZeneca plots China robot offensive to counter price cutsAstraZeneca plots China robot offensive to counter price cuts
    EU approves fifth copy of AbbVieEU approves fifth copy of AbbVie's $18 Billion drug Humira
    Paras Healthcare appoints Devendra Kumar Punia as Corporate Head - ITParas Healthcare appoints Devendra Kumar Punia as Corporate Head - IT
    California: Drugmaker paid doctors to overprescribe HumiraCalifornia: Drugmaker paid doctors to overprescribe Humira
    Biopharmaceutical company fined for misleading investorsBiopharmaceutical company fined for misleading investors
    PrevNext

    Popular Stories

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Cyient gets nod to manufacture assemblies for COVID-19 diagnosis units, X-ray system

    Cyient gets nod to manufacture assemblies for COVID-19 diagnosis units, X-ray system

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Relief to Lupin: High court removes ban its diabetes drug Gluconorm P 30

    Relief to Lupin: High court removes ban its diabetes drug Gluconorm P 30

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok